Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.
about
Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context.An Epidemiological Analysis of Summer Influenza Epidemics in Okinawa.Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.2015 Resurgence of Influenza A (H1N1) 09: Smoldering Pandemic in India?
P2860
Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Seroprevalence of antibody to ...... 0) pandemic wave in Australia.
@ast
Seroprevalence of antibody to ...... 0) pandemic wave in Australia.
@en
type
label
Seroprevalence of antibody to ...... 0) pandemic wave in Australia.
@ast
Seroprevalence of antibody to ...... 0) pandemic wave in Australia.
@en
prefLabel
Seroprevalence of antibody to ...... 0) pandemic wave in Australia.
@ast
Seroprevalence of antibody to ...... 0) pandemic wave in Australia.
@en
P2860
P50
P921
P356
P1476
Seroprevalence of antibody to ...... 0) pandemic wave in Australia.
@en
P2093
David Irving
Terry Nolan
P2860
P304
P356
10.1111/IRV.12225
P577
2013-12-31T00:00:00Z